It is not as if Israeli drugmaker Teva didn’t already have enough on its plate, what with its CEO having been shown the door, a court overturning patents to…

Charles River Laboratories has unloaded QS Pharma, a Philadelphia-area CDMO, months after picking it up as part of its $585 million buyout of WIL Research.

The FDA has again slammed a Japanese drug company in a warning letter, this time for not doing enough to prevent contamination during aseptic filling.

Sun Pharma says it could be a few more quarters before it resolves FDA concerns over its key plant in Halol, a situation that continues to be a drag on its…

Eli Lilly is rethinking plans to add a manufacturing line to a plant in Ireland following President Trump’s call on drugmakers to invest in the U.S.

It is a reversal of fortunes for a Pfizer plant in Australia. The U.S. drugmaker has decided to close the facility and lay off nearly 90 workers after…

A Merck KGaA plant in Goa, India, has run into labor issues over wages and is now having to take steps to avoid product shortages.

Dr. Reddy’s Laboratories said regulatory problems with its substitute supplier may keep it from getting to market this quarter with a generic of blockbuster…

Supply Chain